{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T23:16:45Z","timestamp":1695338205603},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,12,11]],"date-time":"2009-12-11T00:00:00Z","timestamp":1260489600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1007\/s00404-009-1299-2","type":"journal-article","created":{"date-parts":[[2009,12,10]],"date-time":"2009-12-10T05:14:04Z","timestamp":1260422044000},"page":"1045-1049","source":"Crossref","is-referenced-by-count":5,"title":["No association of the G972S polymorphism of the insulin receptor substrate-1 gene with polycystic ovary syndrome in lean PCOS women with biochemical hyperandrogenemia"],"prefix":"10.1007","volume":"281","author":[{"given":"Dimitra J.","family":"Marioli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasiliki","family":"Koika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George L.","family":"Adonakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandros D.","family":"Saltamavros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasia","family":"Karela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasia K.","family":"Armeni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasilios S.","family":"Tsapanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George O.","family":"Decavalas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neoklis A.","family":"Georgopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,12,11]]},"reference":[{"issue":"11","key":"1299_CR1","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","volume":"91","author":"R Azziz","year":"2006","unstructured":"Azziz R, Carmina E, Dewailly D et al (2006) Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline. J Clin Endocrinol Metab 91(11):4237\u20134245","journal-title":"J Clin Endocrinol Metab"},{"key":"1299_CR2","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1210\/jcem.84.6.5803","volume":"84","author":"E Carmina","year":"1999","unstructured":"Carmina E, Lobo RA (1999) Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab 84:1897\u20131899","journal-title":"J Clin Endocrinol Metab"},{"key":"1299_CR3","first-page":"774","volume":"18","author":"A Dunaif","year":"1997","unstructured":"Dunaif A (1997) Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18:774\u2013800","journal-title":"Endocr Rev"},{"issue":"6","key":"1299_CR4","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S0015-0282(02)03111-4","volume":"77","author":"F Ovalle","year":"2002","unstructured":"Ovalle F, Azziz R (2002) Insulin resistance, polycystic ovary syndrome, and type II diabetes mellitus. Fertil Steril 77(6):1095\u20131105","journal-title":"Fertil Steril"},{"key":"1299_CR5","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.2337\/diab.38.9.1165","volume":"38","author":"A Dunaif","year":"1989","unstructured":"Dunaif A, Segal KR, Futterweit W, Dorjansky A (1989) Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38:1164\u20131174","journal-title":"Diabetes"},{"key":"1299_CR6","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.2337\/diab.43.8.1066","volume":"43","author":"CR Kahn","year":"1994","unstructured":"Kahn CR (1994) Banting lecture: insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 43:1066\u20131084","journal-title":"Diabetes"},{"key":"1299_CR7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1210\/rp.56.1.295","volume":"56","author":"AM Venkatesan","year":"2001","unstructured":"Venkatesan AM, Dunaif A, Corbould A (2001) Insulin resistance in polycystic ovary syndrome: progress and paradoxes. Recent Prog Horm Res 56:295\u2013308","journal-title":"Recent Prog Horm Res"},{"key":"1299_CR8","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1096\/fj.01-0009rev","volume":"15","author":"G Sesti","year":"2001","unstructured":"Sesti G, Federici M, Hribal ML, Lauro D, Sbraccia P, Lauro R (2001) Defects of the insulin receptor substrate (IRS) system in human metabolic disorders. FASEB 15:2099\u20132111","journal-title":"FASEB"},{"key":"1299_CR9","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/0140-6736(93)92694-O","volume":"342","author":"K Almind","year":"1993","unstructured":"Almind K, Bjorbaek C, Vestergaard H, Hansen T, Echwald SM, Pedersen O (1993) Aminoacid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes. Lancet 342:828\u2013832","journal-title":"Lancet"},{"key":"1299_CR10","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/BF00410287","volume":"38","author":"GA Hitman","year":"1995","unstructured":"Hitman GA, Hawrami K, McCarthy MI et al (1995) Insulin receptor substrate-1 gene mutations in NIDDM: implications for the study of polygenic disease. Diabetologia 38:481\u2013486","journal-title":"Diabetologia"},{"issue":"8","key":"1299_CR11","doi-asserted-by":"crossref","first-page":"6441","DOI":"10.1074\/jbc.M412300200","volume":"280","author":"AJ McGettrick","year":"2005","unstructured":"McGettrick AJ, Feeners EP, Kahn CR (2005) Human Insulin receptor substrate-1 (IRS-1) polymorphism G972S causes IRS-1 to associate with the insulin receptor and inhibit receptor autophosphorylation. JBC 280(8):6441\u20136446","journal-title":"JBC"},{"key":"1299_CR12","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.2337\/diabetes.50.9.2164","volume":"50","author":"SA El Mkadem","year":"2001","unstructured":"El Mkadem SA, Lautier C, Macari F et al (2001) Role of allelic variants G972S of IRS-1 and Gly1057Asp of IRS-2 in moderate-to-severe insulin resistance of women with polycystic ovary syndrome. Diabetes 50:2164\u20132168","journal-title":"Diabetes"},{"issue":"11","key":"1299_CR13","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1093\/humrep\/dei205","volume":"20","author":"G Villuendas","year":"2005","unstructured":"Villuendas G, Botella-Carretero JI, Rold\u00e1n B, Sancho J, Escobar-Morreale HF, San Mill\u00e1n JL (2005) Polymorphisms in the insulin receptor substrate-1 (IRS-1) gene and the insulin receptor substrate-2 (IRS-2) gene influence glucose homeostasis and body mass index in women with polycystic ovary syndrome and non-hyperandrogenic controls. Hum Reprod 20(11):3184\u20133191","journal-title":"Hum Reprod"},{"issue":"9","key":"1299_CR14","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1210\/jc.2002-020216","volume":"87","author":"DA Ehrmann","year":"2002","unstructured":"Ehrmann DA, Tang X, Yoshiuchi I, Cox NJ, Bell GI (2002) Relationship of insulin receptor substrate-1 and -2 genotypes to phenotypic features of polycystic ovary syndrome. J Clin Endocrinol Metab 87(9):4297\u20134300","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"1299_CR15","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1007\/s001250170001","volume":"44","author":"T Sir-Petermann","year":"2001","unstructured":"Sir-Petermann T, P\u00e9rez-Bravo F, Angel B, Maliqueo M, Calvillan M, Palomino A (2001) G972S polymorphism of the IRS-1 in women with polycystic ovary syndrome. Diabetologia 44(9):1200\u20131201","journal-title":"Diabetologia"},{"key":"1299_CR16","first-page":"377","volume-title":"Polycystic ovary syndrome","author":"JK Zawadski","year":"1992","unstructured":"Zawadski JK, Dunaif A (1992) Diagnostic criteria for polycystic ovary syndrome. In: Dunaif A, Givens JR, Haseltine FP, Merriam GE (eds) Polycystic ovary syndrome. Blackwell, Boston, pp 377\u2013384"},{"key":"1299_CR17","doi-asserted-by":"crossref","unstructured":"The Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on the diagnostic criteria and long term health risks related to polycystic ovary syndrome. Fertil Steril 81(1): 19\u201325","DOI":"10.1016\/j.fertnstert.2003.10.004"},{"key":"1299_CR18","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Mathews","year":"1985","unstructured":"Mathews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and B cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412\u2013419","journal-title":"Diabetologia"},{"key":"1299_CR19","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.fertnstert.2004.01.041","volume":"82","author":"E Carmina","year":"2004","unstructured":"Carmina E, Lobo RA (2004) Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome. Fertil Steril 82:661\u2013665","journal-title":"Fertil Steril"},{"key":"1299_CR20","doi-asserted-by":"crossref","first-page":"550","DOI":"10.2337\/diacare.25.3.550","volume":"25","author":"RM Bezerra","year":"2002","unstructured":"Bezerra RM, de Castro V, Sales T et al (2002) The G972S Polymorphism in insulin receptor substrate-1 is associated with decreased birth weight in a population- based sample of Brazilian newborns. Diabetes Care 25:550\u2013553","journal-title":"Diabetes Care"},{"key":"1299_CR21","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(07)61345-2","volume":"370","author":"RJ Norman","year":"2007","unstructured":"Norman RJ, Dewailly D, Legro RS, Hickey TE (2007) Polycystic ovary syndrome. Lancet 370:685\u2013697","journal-title":"Lancet"},{"key":"1299_CR22","first-page":"1052","volume":"78","author":"J Holte","year":"1994","unstructured":"Holte J, Berg T, Berne C, Berglund L, Lithell H (1994) Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance. J Clin Endocrinol Metab 78:1052\u20131058","journal-title":"J Clin Endocrinol Metab"},{"key":"1299_CR23","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/372186a0","volume":"372","author":"E Araki","year":"1994","unstructured":"Araki E, Myra AL, Patti M et al (1994) Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372:186\u2013189","journal-title":"Nature"},{"key":"1299_CR24","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1128\/MCB.17.3.1513","volume":"17","author":"JC Br\u00fcning","year":"1997","unstructured":"Br\u00fcning JC, Winnay J, Cheatham B, Kahn CR (1997) Differential signalling by insulin receptor substrate 1 (IRS-1) and IRS-2 in IRS-1 deficient mice. Mol Cell Biol 17:1513\u20131521","journal-title":"Mol Cell Biol"},{"key":"1299_CR25","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1073\/pnas.96.15.8573","volume":"96","author":"M Urbanek","year":"1999","unstructured":"Urbanek M, Legro RS, Driscoll DA et al (1999) Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. Proc Natl Acad Sci USA 96:8573\u20138587","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-009-1299-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-009-1299-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-009-1299-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T17:53:57Z","timestamp":1559066037000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-009-1299-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,11]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["1299"],"URL":"https:\/\/doi.org\/10.1007\/s00404-009-1299-2","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,11]]}}}